Influence of local hemostatic and antiplatelet agents on the incidence of bleeding complications in carotid endarterectomies

Standard

Influence of local hemostatic and antiplatelet agents on the incidence of bleeding complications in carotid endarterectomies. / Weinrich, M; Schindler, P; Kundt, G; Klar, E; Bünger, Carsten Michael.

in: CLIN HEMORHEOL MICRO, Jahrgang 58, Nr. 1, 2014, S. 271-9.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{df53cca0d53e48448ef996ca0934e558,
title = "Influence of local hemostatic and antiplatelet agents on the incidence of bleeding complications in carotid endarterectomies",
abstract = "BACKGROUND: For the reduction of cardio- and cerebrovascular events in carotid endarterectomies continuation of antiplatelet medication is recommended perioperatively. As a result, this patient population is at increased risk for postoperative bleeding complications. Intraoperative application of local hemostatic agents might reduce the incidence of bleeding complications.MATERIAL AND METHODS: All 565 patients undergoing carotid endarterectomy between January 2005 and January 2011 were analysed retrospectively. Most patients in the earlier cohort years of the study had no perioperative antiplatelet medication. In contrast antiplatelet medication was usually continued perioperatively in the later cohort years. To reduce the risk of perioperative bleeding local hemostatic agents were applied increasingly.RESULTS: Revision surgery, due to postoperative bleeding or massive hematoma, was necessary in 20 cases (3.5 %). Overall, 383 carotid endarterectomies (67.8 %) were performed with perioperative antiplatelet medication. Local hemostatic agents were applied in 259 cases (45.8 %) intraoperatively. Initially, operations performed in patients taking antiplatelet medication resulted in an increased need for surgical revision. Following an accelerated practice of using local hemostatic agents, the need for revision surgeries fell. Nevertheless, when patients from all years were analysed together there was no significant benefit from the application of local hemostatic agents.CONCLUSION: Application of local hemostatic agents might have contributed to a reduction of bleeding complications in carotid endarterectomies. However, this could not be shown of statistical significance. Other confounding factors such as different operative techniques or forms of anesthesia might also have influenced this decline.",
keywords = "Adult, Aged, Aged, 80 and over, Endarterectomy, Carotid, Female, Hemorrhage, Hemostasis, Hemostatics, Humans, Incidence, Male, Middle Aged, Platelet Aggregation Inhibitors, Retrospective Studies, Journal Article",
author = "M Weinrich and P Schindler and G Kundt and E Klar and B{\"u}nger, {Carsten Michael}",
year = "2014",
doi = "10.3233/CH-141901",
language = "English",
volume = "58",
pages = "271--9",
journal = "CLIN HEMORHEOL MICRO",
issn = "1386-0291",
publisher = "IOS Press",
number = "1",

}

RIS

TY - JOUR

T1 - Influence of local hemostatic and antiplatelet agents on the incidence of bleeding complications in carotid endarterectomies

AU - Weinrich, M

AU - Schindler, P

AU - Kundt, G

AU - Klar, E

AU - Bünger, Carsten Michael

PY - 2014

Y1 - 2014

N2 - BACKGROUND: For the reduction of cardio- and cerebrovascular events in carotid endarterectomies continuation of antiplatelet medication is recommended perioperatively. As a result, this patient population is at increased risk for postoperative bleeding complications. Intraoperative application of local hemostatic agents might reduce the incidence of bleeding complications.MATERIAL AND METHODS: All 565 patients undergoing carotid endarterectomy between January 2005 and January 2011 were analysed retrospectively. Most patients in the earlier cohort years of the study had no perioperative antiplatelet medication. In contrast antiplatelet medication was usually continued perioperatively in the later cohort years. To reduce the risk of perioperative bleeding local hemostatic agents were applied increasingly.RESULTS: Revision surgery, due to postoperative bleeding or massive hematoma, was necessary in 20 cases (3.5 %). Overall, 383 carotid endarterectomies (67.8 %) were performed with perioperative antiplatelet medication. Local hemostatic agents were applied in 259 cases (45.8 %) intraoperatively. Initially, operations performed in patients taking antiplatelet medication resulted in an increased need for surgical revision. Following an accelerated practice of using local hemostatic agents, the need for revision surgeries fell. Nevertheless, when patients from all years were analysed together there was no significant benefit from the application of local hemostatic agents.CONCLUSION: Application of local hemostatic agents might have contributed to a reduction of bleeding complications in carotid endarterectomies. However, this could not be shown of statistical significance. Other confounding factors such as different operative techniques or forms of anesthesia might also have influenced this decline.

AB - BACKGROUND: For the reduction of cardio- and cerebrovascular events in carotid endarterectomies continuation of antiplatelet medication is recommended perioperatively. As a result, this patient population is at increased risk for postoperative bleeding complications. Intraoperative application of local hemostatic agents might reduce the incidence of bleeding complications.MATERIAL AND METHODS: All 565 patients undergoing carotid endarterectomy between January 2005 and January 2011 were analysed retrospectively. Most patients in the earlier cohort years of the study had no perioperative antiplatelet medication. In contrast antiplatelet medication was usually continued perioperatively in the later cohort years. To reduce the risk of perioperative bleeding local hemostatic agents were applied increasingly.RESULTS: Revision surgery, due to postoperative bleeding or massive hematoma, was necessary in 20 cases (3.5 %). Overall, 383 carotid endarterectomies (67.8 %) were performed with perioperative antiplatelet medication. Local hemostatic agents were applied in 259 cases (45.8 %) intraoperatively. Initially, operations performed in patients taking antiplatelet medication resulted in an increased need for surgical revision. Following an accelerated practice of using local hemostatic agents, the need for revision surgeries fell. Nevertheless, when patients from all years were analysed together there was no significant benefit from the application of local hemostatic agents.CONCLUSION: Application of local hemostatic agents might have contributed to a reduction of bleeding complications in carotid endarterectomies. However, this could not be shown of statistical significance. Other confounding factors such as different operative techniques or forms of anesthesia might also have influenced this decline.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Endarterectomy, Carotid

KW - Female

KW - Hemorrhage

KW - Hemostasis

KW - Hemostatics

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Platelet Aggregation Inhibitors

KW - Retrospective Studies

KW - Journal Article

U2 - 10.3233/CH-141901

DO - 10.3233/CH-141901

M3 - SCORING: Journal article

C2 - 25248351

VL - 58

SP - 271

EP - 279

JO - CLIN HEMORHEOL MICRO

JF - CLIN HEMORHEOL MICRO

SN - 1386-0291

IS - 1

ER -